April 5, 2022
Neuropsychotropic Drug Therapy 2020 | Esketamine
Neuropsychotropic Drug Therapy 2020
Esketamine: An Introduction
Matthew Schreiber, MD, PhD
Staff Psychiatrist, VA Puget Sound HCS, Seattle; Assistant Professor, UW Department of Psychiatry and Behavioral Sciences
Advanced practice nurse practitioners, especially psychiatric and family nurse practitioners, clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Gain knowledge about the clinical research data on esketamine.
- Appreciate the potential clinical uses and benefits of esketamine.
- Use esketamine as a learning example of the drug development.